Reducing the ratio between essential fatty acids: C18:2 n–6/C18:3 n–3 down to 5 is recommended by Nutritional Guidelines. We studied the fatty acid (FA) changes in consumers’ plasma following changes in livestock diet. First, a zootechnical study introduced 5% of extruded linseed into the diet of livestock to replace other oleaginous ingredients, and on an iso-nutritional values basis. The products from linseed-fed animals contained more n–3 fatty acids (precursor α-linolenic and derivatives obtained by elongations and desaturations) than control animal products (issued from animals fed without linseed), and more conjugated linoleic acids (CLA). The n–6/n–3 ratio was reduced by 54% in butter, 60% in meat and 86% in eggs. Following this, a double-blind, randomised, cross-over clinical study involving 75 healthy volunteers compared plasma and erythrocyte FA profiles in consumers of animal products (from livestock fed the linseed diet or from livestock fed standard diet). It showed modifications in the FA composition of the experimental human regimen with more C18:3 n–3 (1.65 vs. 0.75 g/day), and more n–3 derivatives. The C18:2 n–6/C18:3 n–3 ratio decreased (7 vs. 15). In volunteers’ plasma, C18:3 n–3 increased in the essay group (0.93 vs. 0.44% of the FA), so did n–3 derivatives and CLA. The n–6/n–3 ratio decreased from 14.3 to 10.2. In erythrocytes, C20:5 n–3 increased in the essay group (0.59 vs. 0.45%) and so did C22:6 n–3. The n–6/n–3 ratio decreased in parallel from 4.2 to 3.8. Without any changes in consumers’ eating habits, foodstuffs from animals fed linseed diets induced significant modifications of human plasma and erythrocyte fatty acid composition (comparable to that noted under the ‘Cretan’ diet) and a sharp increase in CLA.

Keywords:
Linseed, α-Linolenic acid, Conjugated linoleic acid, Polyunsaturated fatty acids, Extrusion, Animal nutrition, Human nutrition, Animal lipids
This content is only available via PDF.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.